×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
16277 views

Programme

18:00
Pourquoi les chirurgiens doivent favoriser les traitements néo-adjuvants ?
Pr Fabien Reyal
 
18:20
Prise en charge des patientes métastatiques synchrones
Pr Jean-Yves Pierga

18:40 Prise en charge des récidives régionales isolées
Dr Sarah Differding
 
19:00 Débat/discussion - Réponses aux questions

 
Réunion modérée par Pr Fabien Reyal

Shooting date : 2021-04-14
Last update : 2022-12-19
2 comments
Join the Discussion
  • Delphine M. Oui je suis là!!!

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Kheloudja B. les tumeurs de 2 cm ou plus HER2 surexprimé , reçoivent une chimiothérapie néoadjuavnte et si pas de yp0yPn0 , du TDM 1 en adjuvant . que disent les données sur les tumemeurs HER2+ qui ne reçoivent de néoadj car petites de taille qui au final recevront herception en adjuvant mais ne connaissant pas leur sensibilité au néoadj , est ce que celles qui n'auraient pas répondu ne rateraient pas le bénéfice du TDM1 en adjuvant , pourquoi pas du néoadj pour toutes lees HER2+?

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Suggestions

      0
      Days
      0
      Hours
      0
      Minutes
      0
      Seconds
      Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
      Honolulu : Wednesday, May 21st 2025 from 06am to 07am (GMT+2)
      San Francisco : Wednesday, May 21st 2025 from 09am to 10am (GMT+2)
      New York : Wednesday, May 21st 2025 from 12pm to 01pm (GMT+2)
      Buenos Aires : Wednesday, May 21st 2025 from 01pm to 02pm (GMT+2)
      Reykjavik : Wednesday, May 21st 2025 from 04pm to 05pm (GMT+2)
      London / Dublin : Wednesday, May 21st 2025 from 05pm to 06pm (GMT+2)
      Paris / Berlin : Wednesday, May 21st 2025 from 06pm to 07pm (GMT+2)
      Istanbul : Wednesday, May 21st 2025 from 07pm to 08pm (GMT+2)
      Moscou / Dubaï : Wednesday, May 21st 2025 from 08pm to 09pm (GMT+2)
      Bangkok : Wednesday, May 21st 2025 from 11pm to 12am (GMT+2)
      Shanghai : Thursday, May 22nd 2025 from 12am to 01am (GMT+2)
      Tokyo : Thursday, May 22nd 2025 from 01am to 02am (GMT+2)
      Sydney : Thursday, May 22nd 2025 from 03am to 04am (GMT+2)
      Wellington : Thursday, May 22nd 2025 from 05am to 06am (GMT+2)

      16th SFCO congress

      ROOM 1 / Latest developments in the management of patients treated for RH+ breast cancer

      Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
      Honolulu : Tuesday, March 28th 2023 from 07am to 08:30am (GMT+2)
      San Francisco : Tuesday, March 28th 2023 from 10am to 11:30am (GMT+2)
      New York : Tuesday, March 28th 2023 from 01pm to 02:30pm (GMT+2)
      Buenos Aires : Tuesday, March 28th 2023 from 02pm to 03:30pm (GMT+2)
      Reykjavik : Tuesday, March 28th 2023 from 05pm to 06:30pm (GMT+2)
      London / Dublin : Tuesday, March 28th 2023 from 06pm to 07:30pm (GMT+2)
      Paris / Berlin : Tuesday, March 28th 2023 from 07pm to 08:30pm (GMT+2)
      Istanbul : Tuesday, March 28th 2023 from 08pm to 09:30pm (GMT+2)
      Moscou / Dubaï : Tuesday, March 28th 2023 from 09pm to 10:30pm (GMT+2)
      Bangkok : Wednesday, March 29th 2023 from 12am to 01:30am (GMT+2)
      Shanghai : Wednesday, March 29th 2023 from 01am to 02:30am (GMT+2)
      Tokyo : Wednesday, March 29th 2023 from 02am to 03:30am (GMT+2)
      Sydney : Wednesday, March 29th 2023 from 04am to 05:30am (GMT+2)
      Wellington : Wednesday, March 29th 2023 from 06am to 07:30am (GMT+2)

      La prise en charge des cancers du sein triple négatifs :

      intégration des innovations thérapeutiques dans les algorithmes et gestion des effets secondaires

      Share
      Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
      Honolulu : Wednesday, May 10th 2023 from 06am to 07:30am (GMT+2)
      San Francisco : Wednesday, May 10th 2023 from 09am to 10:30am (GMT+2)
      New York : Wednesday, May 10th 2023 from 12pm to 01:30pm (GMT+2)
      Buenos Aires : Wednesday, May 10th 2023 from 01pm to 02:30pm (GMT+2)
      Reykjavik : Wednesday, May 10th 2023 from 04pm to 05:30pm (GMT+2)
      London / Dublin : Wednesday, May 10th 2023 from 05pm to 06:30pm (GMT+2)
      Paris / Berlin : Wednesday, May 10th 2023 from 06pm to 07:30pm (GMT+2)
      Istanbul : Wednesday, May 10th 2023 from 07pm to 08:30pm (GMT+2)
      Moscou / Dubaï : Wednesday, May 10th 2023 from 08pm to 09:30pm (GMT+2)
      Bangkok : Wednesday, May 10th 2023 from 11pm to 12:30am (GMT+2)
      Shanghai : Thursday, May 11th 2023 from 12am to 01:30am (GMT+2)
      Tokyo : Thursday, May 11th 2023 from 01am to 02:30am (GMT+2)
      Sydney : Thursday, May 11th 2023 from 03am to 04:30am (GMT+2)
      Wellington : Thursday, May 11th 2023 from 05am to 06:30am (GMT+2)

      Cancer du sein : actualités et essais en cours, vers où allons-nous ?

      Share
      Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Honolulu : Wednesday, March 13th 2024 from 06am to 07:30am (GMT+1)
      San Francisco : Wednesday, March 13th 2024 from 08am to 09:30am (GMT+1)
      New York : Wednesday, March 13th 2024 from 11am to 12:30pm (GMT+1)
      Buenos Aires : Wednesday, March 13th 2024 from 01pm to 02:30pm (GMT+1)
      London / Dublin : Wednesday, March 13th 2024 from 04pm to 05:30pm (GMT+1)
      Paris / Berlin : Wednesday, March 13th 2024 from 05pm to 06:30pm (GMT+1)
      Istanbul : Wednesday, March 13th 2024 from 06pm to 07:30pm (GMT+1)
      Moscou / Dubaï : Wednesday, March 13th 2024 from 08pm to 09:30pm (GMT+1)
      Bangkok : Wednesday, March 13th 2024 from 11pm to 12:30am (GMT+1)
      Shanghai : Thursday, March 14th 2024 from 12am to 01:30am (GMT+1)
      Tokyo : Thursday, March 14th 2024 from 01am to 02:30am (GMT+1)
      Sydney : Thursday, March 14th 2024 from 02am to 03:30am (GMT+1)
      Wellington : Thursday, March 14th 2024 from 04am to 05:30am (GMT+1)

      Prise en charge du cancer HER2+ métastatique

      Cycle d'enseignement - Le cancer du sein

      Share
      Scroll Up